Company: INMB
Filing Date: 2025-01-28
Form Type: 8-K
Source: 0001213900-25-007521
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-01-28
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On January 28, 2025,
INmune Bio Inc. (the “ Company”), issued a press release announcing that the first patient was treated in the Company’s
phase I/II trial in men with metastatic castration-resistant prostate cancer at the West Los Angeles Veterans Administration Hospital.

A copy of the Company’s press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial statements and Exhibits